DMT210 Topical Gel in the Treatment of Acne Rosacea

Acne Rosacea Clinical Trial

Official title:
A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea

Status Completed

Clinical Trial Summary

The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03003104
Study type	Interventional
Source	Dermata Therapeutics
Contact
Status	Completed
Phase	Phase 2
Start date	January 2017
Completion date	August 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03064438` - Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea	Phase 2
Active, not recruiting	`NCT05108025` - DMT310-005 Topical in the Treatment of Acne Rosacea	Phase 2
Completed	`NCT02270411` - Inflammatory Cells From Various Pathologies
Completed	`NCT02147691` - Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study	Phase 4
Recruiting	`NCT04214483` - A Pilot Study to Explore the Role of Gut Flora in Acne
Completed	`NCT00041977` - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea	Phase 3
Completed	`NCT00580723` - Effects of PRK 124 Lotion in Acne Rosacea	Phase 1/Phase 2
Completed	`NCT04555525` - A Pilot Study on the Use of Seysara for Rosacea	Phase 4